Optimal Relaxation Technique for Laparotomies With Rocuronium Infusion Followed by Sugammadex Reversal
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Muscle relaxation using rocuronium infusion with sugammadex reversal hypothetically provide
better quality of muscle relaxation and rapid recovery from anaesthesia compared with
intermittent bolus of rocuronium muscle relaxant which is reversed with neostigmine.
50 patients undergoing major laparotomy surgery with predicted surgical time of more than 90
minutes will be randomised into 2 treatment arms: CI-sugammadex & IB-Neostigmine.
After a bolus of rocuronium given during induction, patients in CI-Sugammadex arm will be
started on rocuronium infusion immediately and rate adjusted according to the targeted PTC of
1-2. Patients randomised to IB-Neostigmine will be given boluses of rocuronium at
reappearance of TOFC of 2.
At the end of the surgery, the subject will be reversed with either sugammadex or neostigmine
at different depth of block, ie PTC 1-2 and TOFC 2 respectively.
Quality of intraoperative relaxation and effectiveness of reversal of the 2 technique,
CI-Sugammadex and IB-Neostigmine will be compared with respect to:
1. Time to full reversal (T4/T1 [TOF] ratios ≥ 0.9) of neuromuscular blockade from:
- PTC 1-2 in CI-Sugammadex group
- TOFC ≥2 in IB-Neostigmine group
2. Incidence of residual neuromuscular blockade (T4/T1 ratios < 0.9)
3. Improved quality of intraoperative neuromuscular relaxation by maintaining profound
neuromuscular blockade, as reflected by reduced incidence of intraoperative events and
high VAS grading of relaxation quality by surgeon